Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Ruxolitinib cream ameliorates a preclinical model of skin dermatitis via modulation of inflammatory T-cell subsets
Home
Publications
Ruxolitinib cream ameliorates a preclinical model of skin dermatitis via modulation of inflammatory T-cell subsets
Ruxolitinib cream ameliorates a preclinical model of skin dermatitis via modulation of inflammatory T-cell subsets
Authors:
MP
Melissa Parker
Melissa Parker
BF
Brittany Fay
Brittany Fay
MS
Monika Scuron
Monika Scuron
EH
Eduardo Huarte
Eduardo Huarte
RC
Robert Collins
Robert Collins
WY
Weqing Yao
Weqing Yao
PS
Paul Smith
Paul Smith
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
10 September 2019
conference paper
Published by
Morressier GmbH
DOI:
10.26226/morressier.5d4980cf8fb7e44098e72f69
Abstract
Allergic contact dermatitis is driven by an overreaction of the body's immune system to a normally harmless substance resulting in skin inflammat |
Keywords
INFLAMMAT
OVERREACTION
HARMLESS
RUXOLITINIB
CREAM AMELIORATES
PRECLINICAL MODEL
MODEL OF SKIN
Related articles
Scroll to top